Novo Nordisk Aktie
47,48
EUR
-0,43
EUR
-0,89
%
46,75
EUR
-1,29
EUR
-2,68
%
Werbung
Novo Nordisk Aktie Analyse
03.02.21 | Novo Nordisk Outperform | Bernstein Research | |
03.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.01.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.01.21 | Novo Nordisk buy | Deutsche Bank AG | |
04.01.21 | Novo Nordisk kaufen | JP Morgan Chase & Co. | |
Werbung
|
|||
01.12.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.11.20 | Novo Nordisk Outperform | Credit Suisse Group | |
30.10.20 | Novo Nordisk kaufen | Bernstein Research | |
30.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
30.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.07.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.05.20 | Novo Nordisk overweight | Barclays Capital | |
07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.20 | Novo Nordisk buy | UBS AG | |
06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.04.20 | Novo Nordisk buy | UBS AG |
Werbung
Werbung